Ablynx
Sanofi is a global healthcare leader dedicated to transforming the practice of medicine through science and innovation. With a rich history spanning over a century, Sanofi focuses on developing medicines and vaccines that improve lives and protect public health. The company is committed to scientific excellence, social impact, sustainability, diversity, and inclusion, aiming to make a positive difference worldwide.
Industries
Nr. of Employees
large (251-1000)
Ablynx
Rua Conde Domingos Papaiz, nº 413, Bairro Jardim Natal, CEP 08.613-010, Suzano/SP
Patents
Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
US-12553901-B2
View DetailsPolypeptides comprising immunoglobulin single variable domains targeting TNFα and IL-23
US-12528860-B2
View DetailsPolypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40L
US-12509522-B2
View Details
Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
US-12553901-B2
View DetailsPolypeptides comprising immunoglobulin single variable domains targeting TNFα and IL-23
US-12528860-B2
View DetailsPolypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40L
US-12509522-B2
View DetailsProducts
Vaccine portfolio
Multiple vaccines covering infectious disease targets and national immunization priorities, developed using multiple platform technologies.
Specialty and general medicines
Portfolio of prescription medicines across immunology, oncology, neurology, rare diseases, diabetes and cardiovascular disease.
Consumer healthcare products (OTC)
Over-the-counter healthcare products for self-care and common conditions, supported by consumer education initiatives.
Vaccine portfolio
Multiple vaccines covering infectious disease targets and national immunization priorities, developed using multiple platform technologies.
Specialty and general medicines
Portfolio of prescription medicines across immunology, oncology, neurology, rare diseases, diabetes and cardiovascular disease.
Consumer healthcare products (OTC)
Over-the-counter healthcare products for self-care and common conditions, supported by consumer education initiatives.
Services
Management and sponsorship of Phase I–IV clinical studies including site selection, investigator engagement, ethics and regulatory submissions, and patient recruitment strategies with remote participation options.
Centralized systems for adverse event intake, assessment and reporting to health authorities and healthcare professionals, with public information resources.
Programs offering education, disease management support and tailored assistance for patients and caregivers living with chronic or complex conditions.
GMP production and regional distribution capabilities for vaccines and pharmaceuticals, supported by inventory management and logistics communications.
Publication of public notices related to product discontinuations, temporary shortages, supply regularization and voluntary recalls to inform regulators, healthcare professionals and the public.
Collaborations with universities, NGOs and community organisations to support education, workforce development and social impact initiatives.
Management and sponsorship of Phase I–IV clinical studies including site selection, investigator engagement, ethics and regulatory submissions, and patient recruitment strategies with remote participation options.
Centralized systems for adverse event intake, assessment and reporting to health authorities and healthcare professionals, with public information resources.
Programs offering education, disease management support and tailored assistance for patients and caregivers living with chronic or complex conditions.
GMP production and regional distribution capabilities for vaccines and pharmaceuticals, supported by inventory management and logistics communications.
Publication of public notices related to product discontinuations, temporary shortages, supply regularization and voluntary recalls to inform regulators, healthcare professionals and the public.
Collaborations with universities, NGOs and community organisations to support education, workforce development and social impact initiatives.
Expertise Areas
- Clinical trial management
- Decentralized and patient‑centric clinical operations
- Vaccine research and manufacturing
- Immunology and inflammation drug development
Key Technologies
- mRNA vaccine platforms
- Biologics manufacturing platforms
- Antibody‑drug conjugates (ADCs)
- Artificial intelligence for drug discovery
News & Updates
Sanofi launched a scholarship program supporting higher education for marginalized groups, including Black, disabled, and LGBTQIAP+ students, in partnership with universities.
Sanofi supports the Crescer Aprendendo project, which promotes early childhood development through family and caregiver training, benefiting over 450 families in vulnerable situations.
Sanofi's Purpose Day involved initiatives like installing water stations and hygiene workshops in Amazonian schools and urban communities, benefiting thousands of children and families.
Sanofi comunicou a descontinuação de vários medicamentos, incluindo Dactil OB, APIDRA SOLOSTAR, Profenid, Flagyl, Caprelsa, entre outros, com detalhes sobre o cronograma de descontinuação.
Sanofi launched a scholarship program supporting higher education for marginalized groups, including Black, disabled, and LGBTQIAP+ students, in partnership with universities.
Sanofi supports the Crescer Aprendendo project, which promotes early childhood development through family and caregiver training, benefiting over 450 families in vulnerable situations.
Sanofi's Purpose Day involved initiatives like installing water stations and hygiene workshops in Amazonian schools and urban communities, benefiting thousands of children and families.
Sanofi comunicou a descontinuação de vários medicamentos, incluindo Dactil OB, APIDRA SOLOSTAR, Profenid, Flagyl, Caprelsa, entre outros, com detalhes sobre o cronograma de descontinuação.